It’s time to say bye-bye to daily insulin injections and hello to Omnipod® 5. Check out the only tubeless, automated insulin delivery system on the market for both Type 1 and Type 2 diabetes today. Omnipod 5 is indicated for people with type 1 diabetes, ages 2 years and older and type 2 diabetes in persons 18 years of age and older. Rx only. WARNING: Do not use SmartAdjust™ technology for people under the age of 2 or who require less than 5 U of insulin per day. Please see omnipod.com/safety for

Ready for a change? Get started on Omnipod® 5 — the first tubeless automated insulin delivery system that integrates with Dexcom G6. This video features sponsored Omnipod® users. Safety info: https://www.omnipod.com/safety | Omnipod UK

The Omnipod DASH® Insulin Management System is a tubeless delivery system that can eliminate up to 14 insulin injections with 1 Pod.* Start with a FREE 30-day trial from the comfort—and safety—of home**. With personalized virtual training and helpful online resources, starting Omnipod® really is as simple as it sounds. Get going today. *Average number of injections required every 3 days (MDI: ~4.5 per day). Data on file. **Do NOT attempt to use the Omnipod DASH™ System before you receive trainin

Now available—a tubeless insulin delivery system that automatically adjusts insulin. Meet the Omnipod 5 System. Get started today with no contract and no commitment. Please see safety information at https://www.omnipod.com/safety 1. Brown et al. Diabetes Care (2021). Study in 240 participants with type 1 diabetes aged 6 - 70 years involving 2 weeks standard therapy followed by 3 months Omnipod 5 use with SmartAdjust technology. | Omnipod

Now available—a tubeless insulin delivery system that automatically adjusts insulin. Meet the Omnipod 5 System. Get started today. Please see safety information at https://www.omnipod.com/safety The Pod has a waterproof IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9